Skip to main content
. 2019 Dec 10;9(1):21–33. doi: 10.1007/s40123-019-00226-9

Table 2.

Adapted from the Clinical Activity Score (CAS). A score of 3 or greater is indicative of active disease that would be responsive to immunosuppressive therapy [23]

Spontaneous orbital pain 1
Pain on up or down gaze 1
Eyelid erythema 1
Conjunctival erythema 1
Eyelid edema 1
Chemosis 1
Caruncular inflammation 1
Increase in proptosis of 2 mm or more between 1 and 3 months 1
Decrease in visual acuity of 1 or more lines between 1 and 3 months 1
Decrease in motility of 5 or more degrees between 1 and 3 months 1